| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| 1 | AN ACT concerning electronic prescriptions. | |||||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||||
| 3 | represented in the General Assembly: | |||||||||||||||||||||
| 4 | Section 5. The Pharmacy Practice Act is amended by | |||||||||||||||||||||
| 5 | changing Section 19 as follows: | |||||||||||||||||||||
| 6 | (225 ILCS 85/19) (from Ch. 111, par. 4139) | |||||||||||||||||||||
| 7 | (Section scheduled to be repealed on January 1, 2028) | |||||||||||||||||||||
| 8 | Sec. 19. Nothing contained in this Act shall be construed | |||||||||||||||||||||
| 9 | to prohibit a pharmacist licensed in this State from filling | |||||||||||||||||||||
| 10 | or refilling a valid prescription for prescription drugs which | |||||||||||||||||||||
| 11 | is on file in a pharmacy licensed in any state and has been | |||||||||||||||||||||
| 12 | transferred from one pharmacy to another by any means, | |||||||||||||||||||||
| 13 | including by way of electronic data processing equipment upon | |||||||||||||||||||||
| 14 | the following conditions and exceptions: | |||||||||||||||||||||
| 15 | (1) Prior to dispensing pursuant to any such | |||||||||||||||||||||
| 16 | prescription, the dispensing pharmacist shall: | |||||||||||||||||||||
| 17 | (a) Advise the patient that the prescription on | |||||||||||||||||||||
| 18 | file at such other pharmacy must be canceled before he | |||||||||||||||||||||
| 19 | or she will be able to fill or refill it. | |||||||||||||||||||||
| 20 | (b) Determine that the prescription is valid and | |||||||||||||||||||||
| 21 | on file at such other pharmacy and that such | |||||||||||||||||||||
| 22 | prescription may be filled or refilled, as requested, | |||||||||||||||||||||
| 23 | in accordance with the prescriber's intent expressed | |||||||||||||||||||||
| |||||||
| |||||||
| 1 | on such prescription. | ||||||
| 2 | (c) Notify the pharmacy where the prescription is | ||||||
| 3 | on file that the prescription must be canceled. | ||||||
| 4 | (d) Record in writing or electronically the | ||||||
| 5 | prescription order, the name of the pharmacy at which | ||||||
| 6 | the prescription was on file, the prescription number, | ||||||
| 7 | the name of the drug and the original amount | ||||||
| 8 | dispensed, the date of original dispensing, and the | ||||||
| 9 | number of remaining authorized refills. | ||||||
| 10 | (e) Obtain the consent of the prescriber to the | ||||||
| 11 | refilling of the prescription when the prescription, | ||||||
| 12 | in the professional judgment of the dispensing | ||||||
| 13 | pharmacist, so requires. | ||||||
| 14 | (2) Upon receipt of a request for prescription | ||||||
| 15 | information set forth in subparagraph (d) of paragraph (1) | ||||||
| 16 | of this Section, if the requested pharmacist is satisfied | ||||||
| 17 | in his professional judgment that such request is valid | ||||||
| 18 | and legal, the requested pharmacist shall: | ||||||
| 19 | (a) Provide such information accurately and | ||||||
| 20 | completely. | ||||||
| 21 | (b) Record electronically or, if in writing, on | ||||||
| 22 | the face of the prescription, the name of the | ||||||
| 23 | requesting pharmacy and pharmacist and the date of | ||||||
| 24 | request. | ||||||
| 25 | (c) Cancel the prescription on file by writing the | ||||||
| 26 | word "void" on its face or the electronic equivalent, | ||||||
| |||||||
| |||||||
| 1 | if not in written format. No further prescription | ||||||
| 2 | information shall be given or medication dispensed | ||||||
| 3 | pursuant to such original prescription. | ||||||
| 4 | (3) In the event that, after the information set forth | ||||||
| 5 | in subparagraph (d) of paragraph (1) of this Section has | ||||||
| 6 | been provided, a prescription is not dispensed by the | ||||||
| 7 | requesting pharmacist, then such pharmacist shall provide | ||||||
| 8 | notice of this fact to the pharmacy from which such | ||||||
| 9 | information was obtained; such notice shall then cancel | ||||||
| 10 | the prescription in the same manner as set forth in | ||||||
| 11 | subparagraph (c) of paragraph (2) of this Section. | ||||||
| 12 | (4) When filling or refilling a valid prescription on | ||||||
| 13 | file in another state, the dispensing pharmacist shall be | ||||||
| 14 | required to follow all the requirements of Illinois law | ||||||
| 15 | which apply to the dispensing of prescription drugs. If | ||||||
| 16 | anything in Illinois law prevents the filling or refilling | ||||||
| 17 | of the original prescription it shall be unlawful to | ||||||
| 18 | dispense pursuant to this Section. | ||||||
| 19 | (5) Prescriptions for drugs in Schedules II, III, IV, | ||||||
| 20 | and V of the Illinois Controlled Substances Act may be | ||||||
| 21 | transferred only once and may not be further transferred, | ||||||
| 22 | consistent with 21 CFR 1306. However, pharmacies | ||||||
| 23 | electronically sharing a real-time, online database may | ||||||
| 24 | transfer up to the maximum refills permitted by the law | ||||||
| 25 | and the prescriber's authorization. | ||||||
| 26 | (Source: P.A. 100-497, eff. 9-8-17.) | ||||||
| |||||||
| |||||||
| 1 | Section 10. The Illinois Controlled Substances Act is | ||||||
| 2 | amended by changing Section 311.6 as follows: | ||||||
| 3 | (720 ILCS 570/311.6) | ||||||
| 4 | Sec. 311.6. Prescriptions for substance classified in | ||||||
| 5 | Schedule II, III, IV, or V sent electronically; exceptions. | ||||||
| 6 | (a) Notwithstanding any other provision of law, a | ||||||
| 7 | prescription for a substance classified in Schedule II, III, | ||||||
| 8 | IV, or V must be sent electronically, in accordance with | ||||||
| 9 | Section 316. Prescriptions sent in accordance with this | ||||||
| 10 | subsection (a) must be accepted by the dispenser in electronic | ||||||
| 11 | format. | ||||||
| 12 | (b) Beginning on January 1, 2024 (the effective date of | ||||||
| 13 | Public Act 103-425) until December 31, 2028, notwithstanding | ||||||
| 14 | any other provision of this Section or any other provision of | ||||||
| 15 | law, a prescriber shall not be required to issue prescriptions | ||||||
| 16 | electronically if he or she certifies to the Department of | ||||||
| 17 | Financial and Professional Regulation that he or she will not | ||||||
| 18 | issue more than 150 prescriptions during a 12-month period. | ||||||
| 19 | Prescriptions in both oral and written form for controlled | ||||||
| 20 | substances shall be included in determining whether the | ||||||
| 21 | prescriber will reach the limit of 150 prescriptions. | ||||||
| 22 | Beginning January 1, 2029, notwithstanding any other provision | ||||||
| 23 | of this Section or any other provision of law, a prescriber | ||||||
| 24 | shall not be required to issue prescriptions electronically if | ||||||
| |||||||
| |||||||
| 1 | he or she certifies to the Department of Financial and | ||||||
| 2 | Professional Regulation that he or she will not issue more | ||||||
| 3 | than 50 prescriptions during a 12-month period. Prescriptions | ||||||
| 4 | in both oral and written form for controlled substances shall | ||||||
| 5 | be included in determining whether the prescriber will reach | ||||||
| 6 | the limit of 50 prescriptions. | ||||||
| 7 | (b-5) Notwithstanding any other provision of this Section | ||||||
| 8 | or any other provision of law, a prescriber shall not be | ||||||
| 9 | required to issue prescriptions electronically under the | ||||||
| 10 | following circumstances: | ||||||
| 11 | (1) prior to January 1, 2026, the prescriber | ||||||
| 12 | demonstrates financial difficulties in buying or managing | ||||||
| 13 | an electronic prescription option, whether it is an | ||||||
| 14 | electronic health record or some other electronic | ||||||
| 15 | prescribing product; | ||||||
| 16 | (2) on and after January 1, 2026, the prescriber | ||||||
| 17 | provides proof of a waiver from the Centers for Medicare | ||||||
| 18 | and Medicaid Services for the Electronic Prescribing for | ||||||
| 19 | Controlled Substances Program due to demonstrated economic | ||||||
| 20 | hardship for the previous compliance year; | ||||||
| 21 | (3) there is a temporary technological or electrical | ||||||
| 22 | failure that prevents an electronic prescription from | ||||||
| 23 | being issued; | ||||||
| 24 | (4) the prescription is for a drug that the | ||||||
| 25 | practitioner reasonably determines would be impractical | ||||||
| 26 | for the patient to obtain in a timely manner if prescribed | ||||||
| |||||||
| |||||||
| 1 | by an electronic data transmission prescription and the | ||||||
| 2 | delay would adversely impact the patient's medical | ||||||
| 3 | condition. This includes prescriptions that may need to be | ||||||
| 4 | filled outside of typical retail pharmacy operating hours | ||||||
| 5 | or that may be difficult to obtain because of drug | ||||||
| 6 | shortages or pharmacy inventory limitations; | ||||||
| 7 | (5) the prescription is for an individual who: | ||||||
| 8 | (A) resides in a nursing or assisted living | ||||||
| 9 | facility; | ||||||
| 10 | (B) is receiving hospice or palliative care; | ||||||
| 11 | (C) is receiving care at an outpatient renal | ||||||
| 12 | dialysis facility and the prescription is related to | ||||||
| 13 | the care provided; | ||||||
| 14 | (D) is receiving care through the United States | ||||||
| 15 | Department of Veterans Affairs; or | ||||||
| 16 | (E) is incarcerated in a state, detained, or | ||||||
| 17 | confined in a correctional facility; | ||||||
| 18 | (6) the prescription prescribes a drug under a | ||||||
| 19 | research protocol; | ||||||
| 20 | (7) the prescription is a non-patient specific | ||||||
| 21 | prescription dispensed under a standing order, approved | ||||||
| 22 | protocol for drug therapy, collaborative drug management, | ||||||
| 23 | or comprehensive medication management, or in response to | ||||||
| 24 | a public health emergency or other circumstance in which | ||||||
| 25 | the practitioner may issue a non-patient specific | ||||||
| 26 | prescription; | ||||||
| |||||||
| |||||||
| 1 | (8) the prescription is issued when the prescriber and | ||||||
| 2 | dispenser are the same entity; | ||||||
| 3 | (9) the prescription is issued for a compound | ||||||
| 4 | prescription containing 2 or more compounds; or | ||||||
| 5 | (10) the prescription is issued by a licensed | ||||||
| 6 | veterinarian within 7 years after November 17, 2023 (the | ||||||
| 7 | effective date of Public Act 103-563). | ||||||
| 8 | (c) The Department of Financial and Professional | ||||||
| 9 | Regulation may adopt rules for the administration of this | ||||||
| 10 | Section to the requirements under this Section that the | ||||||
| 11 | Department of Financial and Professional Regulation may deem | ||||||
| 12 | appropriate. | ||||||
| 13 | (d) Any prescriber who makes a good faith effort to | ||||||
| 14 | prescribe electronically, but for reasons not within the | ||||||
| 15 | prescriber's control is unable to prescribe electronically, | ||||||
| 16 | may be exempt from any disciplinary action. | ||||||
| 17 | (e) Any pharmacist who dispenses in good faith based upon | ||||||
| 18 | a valid prescription that is not prescribed electronically may | ||||||
| 19 | be exempt from any disciplinary action. A pharmacist is not | ||||||
| 20 | required to ensure or responsible for ensuring the | ||||||
| 21 | prescriber's compliance under subsection (b), nor may any | ||||||
| 22 | other entity or organization require a pharmacist to ensure | ||||||
| 23 | the prescriber's compliance with that subsection. A pharmacist | ||||||
| 24 | may not refuse to fill a valid prescription solely because it | ||||||
| 25 | is not prescribed electronically. | ||||||
| 26 | (f) It shall be a violation of this Section for any | ||||||
| |||||||
| |||||||
| 1 | prescriber or dispenser to adopt a policy contrary to this | ||||||
| 2 | Section. | ||||||
| 3 | (g) A compliance action with respect to this Section | ||||||
| 4 | initiated by the Department of Financial and Professional | ||||||
| 5 | Regulation prior to December 31, 2030 is limited to a | ||||||
| 6 | non-disciplinary warning letter or citation, unless the | ||||||
| 7 | prescriber or dispenser fails to abide by the initial | ||||||
| 8 | non-disciplinary warning letter or citation, has acted in bad | ||||||
| 9 | faith, or a pattern of practice in violation of this Section | ||||||
| 10 | occurs. | ||||||
| 11 | (Source: P.A. 103-425, eff. 1-1-24; 103-563, eff. 11-17-23; | ||||||
| 12 | 103-732, eff. 8-2-24; 104-424, eff. 8-15-25.) | ||||||
| 13 | Section 99. Effective date. This Act takes effect upon | ||||||
| 14 | becoming law. | ||||||